Antioxidant effects of the VO (IV) hesperidin complex and its role in cancer chemoprevention SB Etcheverry, EG Ferrer, L Naso, J Rivadeneira, V Salinas, ... JBIC Journal of Biological Inorganic Chemistry 13, 435-447, 2008 | 153 | 2008 |
Synthesis, characterization, antitumoral and osteogenic activities of quercetin vanadyl (IV) complexes EG Ferrer, MV Salinas, MJ Correa, L Naso, DA Barrio, SB Etcheverry, ... JBIC Journal of Biological Inorganic Chemistry 11, 791-801, 2006 | 140 | 2006 |
Promising antioxidant and anticancer (human breast cancer) oxidovanadium (IV) complex of chlorogenic acid. Synthesis, characterization and spectroscopic examination on the … LG Naso, M Valcarcel, M Roura-Ferrer, D Kortazar, C Salado, L Lezama, ... Journal of inorganic biochemistry 135, 86-99, 2014 | 107 | 2014 |
Three new vanadyl (IV) complexes with non-steroidal anti-inflammatory drugs (Ibuprofen, Naproxen and Tolmetin). Bioactivity on osteoblast-like cells in culture SB Etcheverry, DA Barrio, AM Cortizo, PAM Williams Journal of Inorganic Biochemistry 88 (1), 94-100, 2002 | 106 | 2002 |
Antitumor properties of a vanadyl (IV) complex with the flavonoid chrysin [VO (chrysin) 2 EtOH] 2 in a human osteosarcoma model: the role of oxidative stress and apoptosis IE Leon, AL Di Virgilio, V Porro, CI Muglia, LG Naso, PAM Williams, ... Dalton Transactions 42 (33), 11868-11880, 2013 | 92 | 2013 |
Role of oxidative stress in the antitumoral action of a new vanadyl (IV) complex with the flavonoid chrysin in two osteoblast cell lines: relationship with the radical … L Naso, EG Ferrer, L Lezama, T Rojo, SB Etcheverry, P Williams JBIC Journal of Biological Inorganic Chemistry 15, 889-902, 2010 | 87 | 2010 |
Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium (IV) complex with luteolin LG Naso, L Lezama, M Valcarcel, C Salado, P Villacé, D Kortazar, ... Journal of Inorganic Biochemistry 157, 80-93, 2016 | 77 | 2016 |
Biological evaluation of morin and its new oxovanadium (IV) complex as antio-xidant and specific anti-cancer agents LG Naso, L Lezama, T Rojo, SB Etcheverry, M Valcarcel, M Roura, ... Chemico-Biological Interactions 206 (2), 289-301, 2013 | 76 | 2013 |
Synthesis of a new vanadyl (IV) complex with trehalose (TreVO): insulin-mimetic activities in osteoblast-like cells in culture DA Barrio, PAM Williams, AM Cortizo, SB Etcheverry JBIC Journal of Biological Inorganic Chemistry 8, 459-468, 2003 | 70 | 2003 |
Antiproliferative and apoptosis-inducing activity of an oxidovanadium (IV) complex with the flavonoid silibinin against osteosarcoma cells IE Leon, V Porro, AL Di Virgilio, LG Naso, PAM Williams, M Bollati-Fogolín, ... JBIC Journal of Biological Inorganic Chemistry 19, 59-74, 2014 | 66 | 2014 |
Synthesis, structure and antifungal properties of Co (II)–sulfathiazolate complexes S Bellú, E Hure, M Trapé, C Trossero, G Molina, C Drogo, PAM Williams, ... Polyhedron 24 (4), 501-509, 2005 | 63 | 2005 |
Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium (IV) complex. Interactions with bovine serum albumin L Naso, VR Martínez, L Lezama, C Salado, M Valcarcel, EG Ferrer, ... Bioorganic & Medicinal Chemistry 24 (18), 4108-4119, 2016 | 59 | 2016 |
Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium (IV)/silibinin complex LG Naso, EG Ferrer, N Butenko, I Cavaco, L Lezama, T Rojo, ... JBIC Journal of Biological Inorganic Chemistry 16, 653-668, 2011 | 58 | 2011 |
Antioxidant and anticancer effects and bioavailability studies of the flavonoid baicalin and its oxidovanadium (IV) complex JJM Medina, LG Naso, AL Pérez, A Rizzi, EG Ferrer, PAM Williams Journal of Inorganic Biochemistry 166, 150-161, 2017 | 53 | 2017 |
Antitumoral, antihypertensive, antimicrobial, and antioxidant effects of an octanuclear copper (II)-telmisartan complex with an hydrophobic nanometer hole MS Islas, JJ Martinez Medina, LL Lopez Tevez, T Rojo, L Lezama, ... Inorganic Chemistry 53 (11), 5724-5737, 2014 | 46 | 2014 |
Losartan and its interaction with copper (II): Biological effects SB Etcheverry, EG Ferrer, L Naso, DA Barrio, L Lezama, T Rojo, ... Bioorganic & medicinal chemistry 15 (19), 6418-6424, 2007 | 44 | 2007 |
Insights into the mechanisms underlying the antitumor activity of an oxidovanadium (IV) compound with the antioxidant naringenin. Albumin binding studies MS Islas, LG Naso, L Lezama, M Valcarcel, C Salado, M Roura-Ferrer, ... Journal of Inorganic Biochemistry 149, 12-24, 2015 | 43 | 2015 |
Oxovanadium (IV) complexes of quinic acid. Synthesis, characterization and potentiometric study Y Allegretti, EG Ferrer, ACG Baró, PAM Williams Polyhedron 19 (26-27), 2613-2619, 2000 | 42 | 2000 |
Synthesis and characterization of oxovanadium (IV) complexes with saccharides SB Etcheverry, PAM Williams, EJ Baran Carbohydrate research 302 (3-4), 131-138, 1997 | 42 | 1997 |
The interaction of the VO2+ cation with oxidized glutathione EG Ferrer, PAM Williams, EJ Baran Journal of inorganic biochemistry 50 (4), 253-262, 1993 | 41 | 1993 |